Abivax (AAVXF) Current Assets (2022 - 2025)

Abivax has reported Current Assets over the past 4 years, most recently at $641.7 million for Q4 2025.

  • Quarterly results put Current Assets at $641.7 million for Q4 2025, up 251.84% from a year ago — trailing twelve months through Dec 2025 was $641.7 million (up 251.84% YoY), and the annual figure for FY2025 was $622.8 million, up 237.15%.
  • Current Assets for Q4 2025 was $641.7 million at Abivax, up from $182.4 million in the prior quarter.
  • Over the last five years, Current Assets for AAVXF hit a ceiling of $641.7 million in Q4 2025 and a floor of $36.9 million in Q4 2022.
  • Median Current Assets over the past 4 years was $245.0 million (2023), compared with a mean of $292.2 million.
  • Biggest five-year swings in Current Assets: surged 733.54% in 2023 and later plummeted 40.73% in 2024.
  • Abivax's Current Assets stood at $36.9 million in 2022, then surged by 733.54% to $307.7 million in 2023, then plummeted by 40.73% to $182.4 million in 2024, then soared by 251.84% to $641.7 million in 2025.
  • The last three reported values for Current Assets were $641.7 million (Q4 2025), $182.4 million (Q4 2024), and $307.7 million (Q4 2023) per Business Quant data.